AU6047996A - Liposomal cyclosporin formulations as agents for immunosuppr ession and multiple drug resistant indications - Google Patents

Liposomal cyclosporin formulations as agents for immunosuppr ession and multiple drug resistant indications

Info

Publication number
AU6047996A
AU6047996A AU60479/96A AU6047996A AU6047996A AU 6047996 A AU6047996 A AU 6047996A AU 60479/96 A AU60479/96 A AU 60479/96A AU 6047996 A AU6047996 A AU 6047996A AU 6047996 A AU6047996 A AU 6047996A
Authority
AU
Australia
Prior art keywords
immunosuppr
ession
indications
agents
drug resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60479/96A
Inventor
Jill Adler-Moore
Su-Ming Chiang
Karen L. Moynihan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexstar Pharmaceuticals Inc
Original Assignee
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/472,635 external-priority patent/US5656287A/en
Priority claimed from US08/475,294 external-priority patent/US5693336A/en
Application filed by Nexstar Pharmaceuticals Inc filed Critical Nexstar Pharmaceuticals Inc
Publication of AU6047996A publication Critical patent/AU6047996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU60479/96A 1995-06-07 1996-06-06 Liposomal cyclosporin formulations as agents for immunosuppr ession and multiple drug resistant indications Abandoned AU6047996A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US472635 1995-06-07
US08/472,635 US5656287A (en) 1995-06-07 1995-06-07 Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
US08/475,294 US5693336A (en) 1995-06-07 1995-06-07 Blood stable liposomal cyclosporin formulations
PCT/US1996/009053 WO1996040064A1 (en) 1995-06-07 1996-06-06 Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
US475294 1999-12-30

Publications (1)

Publication Number Publication Date
AU6047996A true AU6047996A (en) 1996-12-30

Family

ID=27043845

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60479/96A Abandoned AU6047996A (en) 1995-06-07 1996-06-06 Liposomal cyclosporin formulations as agents for immunosuppr ession and multiple drug resistant indications

Country Status (2)

Country Link
AU (1) AU6047996A (en)
WO (1) WO1996040064A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430592A1 (en) * 1994-08-20 1996-02-22 Max Delbrueck Centrum Liposomal preparation, its preparation and its use
IT1289939B1 (en) * 1997-02-20 1998-10-19 Angelini Ricerche Spa AQUEOUS PHARMACEUTICAL COMPOSITION INCLUDING A HIGHLY WATER INSOLUBLE ACTIVE SUBSTANCE
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
EP2412719A1 (en) 2002-12-02 2012-02-01 Xenome Ltd Chi-conotoxin peptides
ES2383358T3 (en) 2002-12-02 2012-06-20 Xenome Ltd Chi-conotoxin peptides having an N-terminal pyroglutamic acid
EP3813788A1 (en) 2018-06-27 2021-05-05 Breath Therapeutics GmbH Pharmaceutical compositions in lyophilized form

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657961B2 (en) * 1991-04-19 1995-03-30 Nexstar Pharmaceuticals, Inc. Pharmaceutical formulation and process
DE4402867C1 (en) * 1994-01-31 1995-06-14 Rentschler Arzneimittel Liposome(s) contg. encapsulated protein for pharmaceutical or cosmetic use
EP0697214A1 (en) * 1994-07-19 1996-02-21 Vestar, Inc. Liposomal cyclosporin pharmaceutical formulations

Also Published As

Publication number Publication date
WO1996040064A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
AU7572196A (en) Pharmaceutical formulations
EG23826A (en) Pharmaceutical formulations
AU6526896A (en) Substituted aromatic compounds and their pharmaceutical use
AU6995396A (en) Pharmaceutical formulation
IL139235A0 (en) Pharmaceutical preparations
ZA963937B (en) Polysiloxane-polyol macromers their preparation and their use
AU7226796A (en) Game machine and game machine system using same
AU6232096A (en) Aromatic compounds and pharmaceutical compositions containing them
AU3049397A (en) Cyclosporin-containing pharmaceutical composition
AUPN411195A0 (en) Medicinal composition
AU6973396A (en) Pharmaceutical formulation
AU7590096A (en) Drug composition
AU6232196A (en) Aromatic compounds and pharmaceutical compositions containing them
EP0852233A4 (en) Cyclosporin phosphate derivatives and medicinal composition
AU4981896A (en) Liposome composition and method for administering liposome-loadable drugs
EP0769314A3 (en) Game
AU7582696A (en) Pharmaceutical formulation
AU6047996A (en) Liposomal cyclosporin formulations as agents for immunosuppr ession and multiple drug resistant indications
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
AU5774796A (en) Pharmaceutical compositions containing lornoxicam and cyclod extrin
AU4459196A (en) Sustained-release preparation and use
AU1509799A (en) Pharmaceutical composition containing cyclosporin
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use
HUP9602220A2 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
ZA96392B (en) Pharmaceutical formulations